MNPR
Monopar Therapeutics Inc.$66.53-3.79 (-5.39%)Prev Close$70.32·MCap$492.6M·P/E—·Vol176.9K·Yield—
▲
Buys (12M)
1
$104.9K
▼
Sells (12M)
8
$4.66M
◆
Net Activity
Net Seller
$4.55M
●
Active Insiders
8
last 12 mo
Over the past 12 months, insider activity at Monopar Therapeutics Inc. (MNPR) has been dominated by selling, with 1 insider purchase totaling $104.9K and 8 insider sales totaling $4.66M. The most recent insider transaction was by STARR CHRISTOPHER M (director), who sold $659.4K worth of shares on Oct 5, 2026. Monopar Therapeutics Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $492.6M.
MNPR Insider Trading Activity
MNPR Insider Buying Activity
The following table shows recent insider purchases of Monopar Therapeutics Inc. (MNPR) stock reported via SEC Form 4 filings.
MNPR Insider Selling Activity
The following table shows recent insider sales of Monopar Therapeutics Inc. (MNPR) stock reported via SEC Form 4 filings.